Type:
Educational Exhibit
Keywords:
MR, CT, Oncology, Genital / Reproductive system female, Staging, Neoplasia, Obstetrics
Authors:
R. Patel, P. WYLIE, R. Patel, N. Bharwani; London/UK
DOI:
10.1594/ecr2011/C-1373
Conclusion
The FIGO staging system for endometrial carcinoma has changed significantly in the 2009 modification,
with simplification of myometrial invasion,
cervical involvement,
peritoneal cytology and nodal disease.
Imaging is not considered to be part of formal FIGO staging for endometrial carcinoma,
but it has a vital role in the triage of patients with cytologically or histologically diagnosed endometrial malignancy,
both in terms of surgical selection and those likely to require adjuvant therapy.
Further research is required in DW-MRI for assessment of myometrial invasion and the use of USPIOs and 18F-FDG PET/CT in more accurate assessment of lymph node involvement.